News report 📈 Stocks 🌍 United States

SpaceX Outpaces Rocket Lab as NASA StarBurst Mission Squeezes Small Launchers

SpaceX leverages massive cash reserves and operational scale to outmaneuver Rocket Lab, which remains a high-beta growth play burdened by dilution and execution risks.

📅 September 18, 2026 🕐 1 min read

2 assets impacted (Stocks). Net bias: 1 Bullish, 1 Bearish, 0 Neutral. Strongest signal: RKLB ↓ 6/10 (62% confidence).

📊 Affected Assets (2)

RKLB

Bearish 🤖 62%

🗓️ Long-term 🌍 US · Explicit

Rocket Lab loses a NASA mission to SpaceX's Falcon 9 rideshare, and its negative EBITDA and dilution make it a riskier retirement investment.

SPCX

Bullish 🤖 60%

🗓️ Long-term 🌍 US · Explicit

NASA awarded SpaceX the StarBurst rideshare mission, and SpaceX demonstrates superior cash flow and balance sheet strength.

🎯 Key Takeaways

SpaceX reported $3.54 billion in quarterly EBITDA, contrasting with Rocket Lab's ongoing negative EBITDA.
The StarBurst mission award highlights a structural trend where SpaceX's rideshare model siphons demand from dedicated small-launch providers.
Rocket Lab's 137% backlog growth and Neutron rocket development offer high upside for risk-tolerant investors, despite a 2.6 beta and significant share dilution.

📝 Executive Summary

SpaceX secures the NASA StarBurst mission, reinforcing its dominance in the launch market through superior cash flow and a $93.5 billion balance sheet. While Rocket Lab offers significant growth potential through its upcoming Neutron rocket, its negative EBITDA and heavy dilution profile present higher risks for conservative portfolios.

❓ FAQ

Why is SpaceX considered a safer bet for retirement-focused portfolios than Rocket Lab?

SpaceX maintains a $93.5 billion cash pile and positive EBITDA, providing downside protection and capital preservation that Rocket Lab, which relies on share dilution and faces negative EBITDA, currently lacks.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article